Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism

BMC Cell Biology

Volumn 10, Issue , 2009, Pages 73-

  Osses, Nelson ^a,b   Casar, Juan C ^a,c   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CELL RECEPTOR; MYOD PROTEIN; MYOGENIC FACTOR 5; OSTEOCALCIN; PROTEOGLYCAN; SODIUM CHLORATE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; DEVELOPMENTAL GENE; ENDOMYSIUM; ENZYME INDUCTION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VIVO STUDY; MONONUCLEAR CELL; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; NONHUMAN; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SULFATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CHLORATES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX; MICE; MUSCLE FIBERS, SKELETAL; MYOBLASTS; MYOGENIC REGULATORY FACTORS; OSTEOCALCIN; PROTEOGLYCANS;

EID: 70449514551     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-10-73     Document Type: Article

References (61)

1. Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol 2002, 3:187-194. 10.1038/nrm761, 11994739.
2. Buckingham M. Making muscle in mammals. Trends Genet 1992, 8:144-148.
3. Brand-Saberi B. Genetic and epigenetic control of skeletal muscle development. Ann Anat 2005, 187:199-207. 10.1016/j.aanat.2004.12.018, 16130819.
4. Anastasi S, Giordano S, Sthandier O, Gambarotta G, Maione R, Comoglio P, Amati P. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J Cell Biol 1997, 137:1057-1068. 10.1083/jcb.137.5.1057, 2136220, 9166406.
5. Brunetti A, Goldfine ID. Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J Biol Chem 1990, 265:5960-5963.
6. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC, Sporn MB. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem 1986, 261:16509-16513.
7. Halevy O, Lerman O. Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-alpha. J Cell Physiol 1993, 154:566-572. 10.1002/jcp.1041540315, 8382210.
8. Nandan D, Clarke EP, Ball EH, Sanwal BD. Ethyl-3,4-dihydroxybenzoate inhibits myoblast differentiation: evidence for an essential role of collagen. J Cell Biol 1990, 110:1673-1679. 10.1083/jcb.110.5.1673, 2200177, 2159480.
9. Saitoh O, Periasamy M, Kan M, Matsuda R. cis-4-Hydroxy-L-proline and ethyl-3,4-dihydroxybenzoate prevent myogenesis of C2C12 muscle cells and block MyoD1 and myogenin expression. Exp Cell Res 1992, 200:70-76. 10.1016/S0014-4827(05)80072-2, 1373388.
10. Menko AS, Boettiger D. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell 1987, 51:51-57. 10.1016/0092-8674(87)90009-2, 3115595.
11. Osses N, Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol Cell Physiol 2002, 282:C383-394.
12. Melo F, Carey DJ, Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J Cell Biochem 1996, 62:227-239. 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I, 8844403.
13. Grounds MD, White JD, Rosenthal N, Bogoyevitch MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 2002, 50:589-610.
14. Tare RS, Babister JC, Kanczler J, Oreffo RO. Skeletal stem cells: phenotype, biology and environmental niches informing tissue regeneration. Mol Cell Endocrinol 2008, 288:11-21. 10.1016/j.mce.2008.02.017, 18395331.
15. Yablonka-Reuveni Z, Day K, Vine A, Shefer G. Defining the transcriptional signature of skeletal muscle stem cells. J Anim Sci 2008, 86:E207-216. 10.2527/jas.2007-0473, 17878281.
16. Kuang S, Gillespie MA, Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008, 2:22-31. 10.1016/j.stem.2007.12.012, 18371418.
17. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766. 10.1083/jcb.127.6.1755, 2120318, 7798324.
18. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253. 10.1046/j.1432-0436.2001.680412.x, 11776477.
19. Connolly AM, Pestronk A, Planer GJ, Yue J, Mehta S, Choksi R. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining. Neurology 1996, 46:810-814.
20. Cros D, Pearson C, Verity MA. Polymyositis-dermatomyositis: diagnostic and prognostic significance of muscle alkaline phosphatase. Am J Pathol 1980, 101:159-176. 1903575, 7446698.
21. Kar NC, Pearson CM. Alkaline phosphatase in normal and diseased human muscle. Proc Soc Exp Biol Med 1972, 141:4-6.
22. Kirkeby S, Moe D. Biochemical and histochemical studies on alkaline phosphatase in normal and dystrophic muscle. Exp Pathol 1985, 27:131-136.
23. Allamand V, Campbell KP. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 2000, 9:2459-2467. 10.1093/hmg/9.16.2459, 11005802.
24. Caceres S, Cuellar C, Casar JC, Garrido J, Schaefer L, Kresse H, Brandan E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur J Cell Biol 2000, 79:173-181. 10.1078/S0171-9335(04)70020-5, 10777109.
25. Fadic R, Mezzano V, Alvarez K, Cabrera D, Holmgren J, Brandan E. Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med 2006, 10:758-769. 10.1111/j.1582-4934.2006.tb00435.x, 16989735.
26. Mezzano V, Cabrera D, Vial C, Brandan E. Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2. J Cell Commun Signal 2007, 1:205-217. 10.1007/s12079-008-0018-2, 2443238, 18600480.
27. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci 2004, 117:73-84. 10.1242/jcs.00828, 14627628.
28. Casar JC, McKechnie BA, Fallon JR, Young MF, Brandan E. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol 2004, 268:358-371. 10.1016/j.ydbio.2003.12.025, 15063173.
29. Humphries DE, Silbert JE. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 1988, 154:365-371. 10.1016/0006-291X(88)90694-8, 2969240.
30. Ugarte G, Brandan E. Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability. J Biol Chem 2006, 281:18473-18481. 10.1074/jbc.M600918200, 16682418.
31. Levy MM, Joyner CJ, Virdi AS, Reed A, Triffitt JT, Simpson AH, Kenwright J, Stein H, Francis MJ. Osteoprogenitor cells of mature human skeletal muscle tissue: an in vitro study. Bone 2001, 29:317-322. 10.1016/S8756-3282(01)00585-3, 11595613.
32. Ouyang X, Fujimoto M, Nakagawa R, Serada S, Tanaka T, Nomura S, Kawase I, Kishimoto T, Naka T. SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J Cell Physiol 2006, 207:428-436. 10.1002/jcp.20579, 16419040.
33. Le Grand F, Rudnicki MA. Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol 2007, 19:628-633. 10.1016/j.ceb.2007.09.012, 2215059, 17996437.
34. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764. 10.1016/S0092-8674(00)80258-5, 9182763.
35. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771. 10.1016/S0092-8674(00)80259-7, 9182764.
36. Wada MR, Inagawa-Ogashiwa M, Shimizu S, Yasumoto S, Hashimoto N. Generation of different fates from multipotent muscle stem cells. Development 2002, 129:2987-2995.
37. Liu CJ, Chang E, Yu J, Carlson CS, Prazak L, Yu XP, Ding B, Lengyel P, Di Cesare PE. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation. J Biol Chem 2005, 280:2788-2796. 10.1074/jbc.M412604200, 15557274.
38. Caldwell CJ, Mattey DL, Weller RO. Role of the basement membrane in the regeneration of skeletal muscle. Neuropathol Appl Neurobiol 1990, 16:225-238. 10.1111/j.1365-2990.1990.tb01159.x, 2402330.
39. Gulati AK, Reddi AH, Zalewski AA. Changes in the basement membrane zone components during skeletal muscle fiber degeneration and regeneration. J Cell Biol 1983, 97:957-962. 10.1083/jcb.97.4.957, 2112627, 6225786.
40. Slack JM. Epithelial metaplasia and the second anatomy. Lancet 1986, 2:268-271. 10.1016/S0140-6736(86)92083-0, 2874289.
41. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000, 356:2079-2085. 10.1016/S0140-6736(00)03411-5, 11145505.
42. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987, 48:549-554. 10.1016/0092-8674(87)90233-9, 3028640.
43. Yamada KM. Integrin signaling. Matrix Biol 1997, 16:137-141. 10.1016/S0945-053X(97)90001-9, 9402002.
44. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 1995, 92:9856-9860. 10.1073/pnas.92.21.9856, 40901, 7568232.
45. Feldman G, Li M, Martin S, Urbanek M, Urtizberea JA, Fardeau M, LeMerrer M, Connor JM, Triffitt J, Smith R. Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am J Hum Genet 2000, 66:128-135. 10.1086/302724, 1288317, 10631143.
46. Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 1999, 140:2125-2133. 10.1210/en.140.5.2125, 10218963.
47. Gutierrez J, Osses N, Brandan E. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. J Cell Physiol 2006, 206:58-67. 10.1002/jcp.20428, 15920756.
48. Abe T, Abe Y, Aida Y, Hara Y, Maeda K. Extracellular matrix regulates induction of alkaline phosphatase expression by ascorbic acid in human fibroblasts. J Cell Physiol 2001, 189:144-151. 10.1002/jcp.10011, 11598899.
49. Bosch P, Musgrave DS, Lee JY, Cummins J, Shuler T, Ghivizzani TC, Evans T, Robbins TD, Huard. Osteoprogenitor cells within skeletal muscle. J Orthop Res 2000, 18:933-944. 10.1002/jor.1100180613, 11192254.
50. Engel WK, Cunningham GG. Alkaline phosphatase-positive abnormal muscle fibers of humans. J Histochem Cytochem 1970, 18:55-57.
51. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528-1530. 10.1126/science.279.5356.1528, 9488650.
52. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M, Mora M, De Angelis MG, Fiocco R, Cossu G, Vescovi AL. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000, 3:986-991. 10.1038/79924, 11017170.
53. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
54. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 1999, 96:14482-14486. 10.1073/pnas.96.25.14482, 24462, 10588731.
55. Tamaki T, Akatsuka A, Ando K, Nakamura Y, Matsuzawa H, Hotta T, Roy RR, Edgerton VR. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002, 157:571-577. 10.1083/jcb.200112106, 2173851, 11994315.
56. Larrain J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J Biol Chem 1997, 272:18418-18424. 10.1074/jbc.272.29.18418, 9218485.
57. Cabello-Verrugio C, Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem 2007, 282:18842-18850. 10.1074/jbc.M700243200, 17485468.
58. Silberstein L, Webster SG, Travis M, Blau HM. Developmental progression of myosin gene expression in cultured muscle cells. Cell 1986, 46:1075-1081. 10.1016/0092-8674(86)90707-5, 3530499.
59. Andress DL. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J Biol Chem 1995, 270:28289-28296.
60. Mereau A, Grey L, Piquet-Pellorce C, Heath JK. Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix. J Cell Biol 1993, 122:713-719. 10.1083/jcb.122.3.713, 2119673, 8335694.
61. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980, 102:344-352. 10.1016/0003-2697(80)90165-7, 6158890.